Cadrenal Therapeutics (CVKD) Earnings Date, Estimates & Call Transcripts $16.32 +0.87 (+5.63%) Closing price 04/15/2025 04:00 PM EasternExtended Trading$16.10 -0.22 (-1.35%) As of 04/15/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Cadrenal Therapeutics Earnings Summary Upcoming Earnings DateMay. 8EstimatedConsensus EPS (Mar. 13) -$1.71 Actual EPS (Mar. 13) -$2.74 Missed By -$1.03 Cadrenal Therapeutics announced Q4 2024 earnings on March 13, 2025, reporting an EPS of -$2.74, which missed analysts' consensus estimates of -$1.71 by $1.03. With a trailing EPS of -$8.67, Cadrenal Therapeutics' earnings are expected to grow next year, from ($7.59) to ($3.81) per share. Q4 2024 Earnings ResourcesQ4 2024 Earnings Report Annual Report (10-K) Press Release (8-K)CVKD Upcoming EarningsCadrenal Therapeutics' Q1 2025 earnings is scheduled for Thursday, May 8, 2025, with a conference call scheduled on Wednesday, May 7, 2025 at 6:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.Powered by Get Cadrenal Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Cadrenal Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataCVKD Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Remove Ads Cadrenal Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$2.15-$1.13-$1.64Q2 20252-$1.26-$1.24-$1.25Q3 20252-$1.43-$1.39-$1.41Q4 20252-$1.42-$1.15-$1.29FY 20258($6.26)($4.91)($5.59) Remove Ads Cadrenal Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/8/2025(Estimated)--------3/13/2025Q4 2024-$1.71-$2.74 -$1.03-$2.74--11/7/2024--$1.83-$2.18 -$0.35-$2.18--8/7/2024Q2 2024-$285.60-$33.75+$251.85-$2.25--5/9/2024Q1 2024-$0.07-$0.10 -$0.03-$0.10--3/11/2024Q4 2023-$0.09-$0.05+$0.04-$0.05--11/9/2023Q3 2023--$0.07 -$0.07-$0.07--8/10/2023Q2 2023--$0.09 -$0.09-$0.09--5/10/2023Q1 2023--$0.41 -$0.41-$0.34-- Cadrenal Therapeutics Earnings - Frequently Asked Questions When is Cadrenal Therapeutics's earnings date? Cadrenal Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 8th, 2025 based off last year's report dates. Learn more on CVKD's earnings history. Did Cadrenal Therapeutics beat their earnings estimates last quarter? In the previous quarter, Cadrenal Therapeutics (NASDAQ:CVKD) missed the analysts' consensus estimate of ($1.71) by $1.03 with a reported earnings per share (EPS) of ($2.74). Learn more on analysts' earnings estimate vs. CVKD's actual earnings. How much profit does Cadrenal Therapeutics generate each year? Cadrenal Therapeutics (NASDAQ:CVKD) has a recorded net income of -$8.36 million. CVKD has generated -$8.67 earnings per share over the last four quarters. What is Cadrenal Therapeutics's EPS forecast for next year? Cadrenal Therapeutics's earnings are expected to grow from ($7.59) per share to ($3.81) per share in the next year. More Earnings Resources from MarketBeat Related Companies Eupraxia Pharmaceuticals Earnings Fate Therapeutics Earnings Alector Earnings Seres Therapeutics Earnings Enanta Pharmaceuticals Earnings FitLife Brands Earnings XBiotech Earnings Coherus BioSciences Earnings SELLAS Life Sciences Group Earnings C4 Therapeutics Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Why Analysts Boosted United Airlines Stock Ahead of EarningsLamb Weston Stock Rises, Earnings Provide Calm Amidst ChaosIntuitive Machines Gains After Earnings Beat, NASA Missions AheadCintas Delivers Earnings Beat, Signals More Growth AheadNike Stock Dips on Earnings: Analysts Weigh in on What’s NextAfter Massive Post Earnings Fall, Does Hope Remain for MongoDB?Semtech Rallies on Earnings Beat—Is There More Upside? Remove Ads This page (NASDAQ:CVKD) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersThe Crypto Market is About to Change LivesI've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredTwo Unmistakable Patterns Return…The signs suggest we're entering one of those rare periods now. That's why Central Banks are buying gold at...Golden Portfolio | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredFirst look: The $3,500 iPhoneDid you hear that just before Trump's tariffs took effect, Apple sent five cargo planes packed with MacBooks a...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cadrenal Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cadrenal Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CVKD Stock Free CVKD Stock Alerts